S
Svas Biosana SpA
MIL:SVS
Svas Biosana SpA
MIL:SVS
Price:
8.86
EUR
-0.23%
Market Cap:
€47.3m
Balance Sheet
Balance Sheet Decomposition
Svas Biosana SpA
Svas Biosana SpA
Balance Sheet Decomposition is not available for
Svas Biosana SpA
Svas Biosana SpA
Balance Sheet
Svas Biosana SpA
Svas Biosana SpA
Currency: EUR
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
3
|
3
|
7
|
30
|
22
|
34
|
33
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
3
|
3
|
7
|
30
|
22
|
34
|
33
|
|
| Short-Term Investments |
1
|
1
|
1
|
1
|
8
|
6
|
4
|
|
| Total Receivables |
33
|
33
|
34
|
35
|
44
|
49
|
51
|
|
| Accounts Receivables |
27
|
30
|
29
|
32
|
39
|
41
|
46
|
|
| Other Receivables |
6
|
3
|
5
|
4
|
5
|
8
|
5
|
|
| Inventory |
22
|
22
|
25
|
25
|
30
|
33
|
34
|
|
| Other Current Assets |
1
|
1
|
1
|
1
|
2
|
2
|
2
|
|
| Total Current Assets |
59
|
60
|
67
|
93
|
105
|
124
|
125
|
|
| PP&E Net |
26
|
27
|
26
|
26
|
26
|
27
|
27
|
|
| Intangible Assets |
5
|
5
|
8
|
10
|
10
|
11
|
12
|
|
| Goodwill |
2
|
2
|
1
|
1
|
1
|
1
|
0
|
|
| Note Receivable |
3
|
6
|
6
|
6
|
3
|
3
|
2
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Other Assets |
2
|
2
|
1
|
1
|
1
|
1
|
0
|
|
| Total Assets |
95
N/A
|
100
+5%
|
108
+8%
|
136
+26%
|
146
+8%
|
166
+13%
|
166
0%
|
|
| Liabilities | ||||||||
| Accounts Payable |
22
|
22
|
22
|
23
|
28
|
31
|
29
|
|
| Accrued Liabilities |
1
|
1
|
2
|
2
|
2
|
2
|
1
|
|
| Short-Term Debt |
21
|
27
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
22
|
20
|
21
|
21
|
23
|
27
|
28
|
|
| Other Current Liabilities |
5
|
5
|
4
|
3
|
4
|
4
|
4
|
|
| Total Current Liabilities |
71
|
75
|
49
|
50
|
57
|
65
|
62
|
|
| Long-Term Debt |
0
|
0
|
29
|
33
|
32
|
40
|
38
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Total Liabilities |
73
N/A
|
77
+6%
|
80
+4%
|
85
+6%
|
92
+8%
|
107
+16%
|
103
-4%
|
|
| Equity | ||||||||
| Common Stock |
15
|
15
|
15
|
21
|
21
|
21
|
21
|
|
| Retained Earnings |
4
|
4
|
9
|
12
|
15
|
20
|
25
|
|
| Additional Paid In Capital |
4
|
4
|
4
|
18
|
18
|
18
|
18
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
2
|
2
|
2
|
2
|
2
|
|
| Treasury Stock |
0
|
0
|
2
|
2
|
2
|
3
|
3
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
22
N/A
|
23
+2%
|
28
+22%
|
51
+84%
|
55
+7%
|
59
+8%
|
63
+7%
|
|
| Total Liabilities & Equity |
95
N/A
|
100
+5%
|
108
+8%
|
136
+26%
|
146
+8%
|
166
+13%
|
166
0%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
6
|
6
|
6
|
5
|
5
|
5
|
5
|
|
Switch to:
Switch to:
See Also
Discover More
